Anavex Life Sciences (AVXL) EBT (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47.78% |
| Sep 30, 2025 | 25.00% |
| Jun 30, 2025 | -15.55% |
| Mar 31, 2025 | 7.94% |
| Dec 31, 2024 | -15.74% |
| Sep 30, 2024 | 4.37% |
| Jun 30, 2024 | -17.62% |
| Mar 31, 2024 | -22.30% |
| Dec 31, 2023 | 16.39% |
| Sep 30, 2023 | 9.16% |
| Jun 30, 2023 | 13.92% |
| Mar 31, 2023 | -0.50% |
| Dec 31, 2022 | 7.73% |
| Sep 30, 2022 | -14.67% |
| Jun 30, 2022 | -17.98% |
| Mar 31, 2022 | 4.09% |
| Dec 31, 2021 | 6.25% |
| Sep 30, 2021 | -14.15% |
| Jun 30, 2021 | -24.76% |
| Mar 31, 2021 | -4.26% |
| Dec 31, 2020 | -30.88% |
| Sep 30, 2020 | 8.10% |
| Jun 30, 2020 | 10.43% |
| Mar 31, 2020 | -9.93% |
| Dec 31, 2019 | -17.54% |
| Sep 30, 2019 | 13.88% |
| Jun 30, 2019 | 9.67% |
| Mar 31, 2019 | -4.16% |
| Dec 31, 2018 | -24.37% |
| Sep 30, 2018 | -95.04% |
| Jun 30, 2018 | 39.69% |
| Mar 31, 2018 | -16.65% |
| Dec 31, 2017 | 21.29% |
| Sep 30, 2017 | -42.92% |
| Jun 30, 2017 | -133.86% |
| Mar 31, 2017 | 50.59% |
| Dec 31, 2016 | 52.10% |
| Sep 30, 2016 | -191.14% |